Literature DB >> 19454446

Management of cancer pain: ESMO clinical recommendations.

L Jost1, F Roila.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19454446     DOI: 10.1093/annonc/mdp164

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Alleviation of cancerous pain by external compress with Xiaozheng Zhitong Paste.

Authors:  Yan-ju Bao; Bao-jin Hua; Wei Hou; Hong-sheng Lin; Xian-bin Zhang; Gui-xiang Yang
Journal:  Chin J Integr Med       Date:  2010-08-10       Impact factor: 1.978

Review 2.  Tramadol/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain.

Authors:  Sohita Dhillon
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience.

Authors:  Escarlata López Ramírez
Journal:  Support Care Cancer       Date:  2012-12-15       Impact factor: 3.603

Review 4.  Integrating palliative care into the trajectory of cancer care.

Authors:  David Hui; Eduardo Bruera
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

5.  Diagnosis and Treatment of Five Pain-Related Conditions in Urban China: A Population-Based Cross-Sectional National Health and Wellness Survey.

Authors:  Bifa Fan; Shuiqing Li; Baishan Wu; Jinghua Zhang; Jing Zhou
Journal:  J Pain Res       Date:  2022-06-23       Impact factor: 2.832

6.  Neuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.

Authors:  Chao Zhu; Jun Tang; Tan Ding; Lei Chen; Wei Wang; Xiao-Peng Mei; Xiao-Tao He; Wen Wang; Li-Dong Zhang; Yu-Lin Dong; Zhuo-Jing Luo
Journal:  Pain       Date:  2017-05       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.